Learning objectives

After watching this webinar, participants will:

appreciate the use of high-sensitivity concentrations of cardiac troponin T or cardiac troponin I as a quantitative marker of chronic cardiomyocyte injury in stable ASCVD;
gain insights into how management of patients with stable ASCVD could be facilitated by using high sensitivity cardiac troponin T or cardiac troponin I;
understand the need for additional investigation to identify the predominate cardiac pathology underlying increased high sensitivity cardiac troponin T or cardiac troponin I concentration in stable ASCVD; and
appreciate finding answers to the remaining questions regarding the possible use of high sensitivity cardiac troponin T or cardiac troponin I for stable ASCVD.

Read the article: High-sensitivity cardiac troponin in stable atherosclerotic vascular disease